Metabotropic glutamate receptor type 1 (Grm1) at play in the glomerular filtration barrier

被引：0
|
作者：
Puliti, A. [1 ,2 ]
Conti, V. [1 ,3 ]
Caridi, G.
Corbelli, A.
Musante, L. [3 ,4 ]
Piccardi, F. [6 ]
Guenet, J. L. [7 ]
Candiano, G. [4 ]
Gusmano, R. [3 ]
Ravazzolo, R. [1 ,2 ]
Rastaldi, M. P. [5 ]
机构：
[1] G Gaslini Inst Children, Mol Genet & Cytogenet Unit, Genoa, Italy
[2] Univ Genoa, Dept Pediat Sci G De Toni, Genoa, Italy
[3] G Gaslini Inst Children, RenalChild Fdn, Genoa, Italy
[4] Gaslini Inst, Lab Pathophysiol Uremia, Genoa, Italy
[5] DAmico Renal Fdn, Renal Immunopathol Lab, Milan, Italy
[6] Ist Nazl Ric Canc, Anim Models Facil, I-16132 Genoa, Italy
[7] Inst Pasteur, Paris, France
来源：
NEUROPHARMACOLOGY | 2008年 / 55卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
112
引用
收藏
页码：619 / 619
页数：1
相关论文
共 50 条
  • [1] Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells
    J J Martino
    B A Wall
    E Mastrantoni
    B J Wilimczyk
    S N La Cava
    K Degenhardt
    E White
    S Chen
    Oncogene, 2013, 32 : 4366 - 4376
  • [2] Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells
    Martino, J. J.
    Wall, B. A.
    Mastrantoni, E.
    Wilimczyk, B. J.
    La Cava, S. N.
    Degenhardt, K.
    White, E.
    Chen, S.
    ONCOGENE, 2013, 32 (37) : 4366 - 4376
  • [3] Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation
    Shin, Seung-Shick
    Namkoong, Jin
    Wall, Brian A.
    Gleason, Ryan
    Lee, Hwa Jin
    Chen, Suzie
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (03) : 368 - 378
  • [4] Concurrent Targeting of Glutaminolysis and Metabotropic Glutamate Receptor 1 (GRM1) Reduces Glutamate Bioavailability in GRM1+ Melanoma
    Shah, Raj
    Singh, Simar J.
    Eddy, Kevinn
    Filipp, Fabian, V
    Chen, Suzie
    CANCER RESEARCH, 2019, 79 (08) : 1799 - 1809
  • [5] AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)
    Shin, Seung-Shick
    Wall, Brian A.
    Goydos, James S.
    Chen, Suzie
    PIGMENT CELL & MELANOMA RESEARCH, 2010, 23 (01) : 103 - 111
  • [6] The metabotropic glutamate receptor 1, GRM1: evaluation as a candidate gene for inherited forms of cerebellar ataxia
    Pia Irene Anna Rossi
    Carlotta Maria Vaccari
    Alessandra Terracciano
    Laura Doria-Lamba
    Sabrina Facchinetti
    Manuela Priolo
    Carmen Ayuso
    Laura De Jorge
    Stefania Gimelli
    Filippo Maria Santorelli
    Roberto Ravazzolo
    Aldamaria Puliti
    Journal of Neurology, 2010, 257 : 598 - 602
  • [7] Somatic Mutations in GRM1 in Cancer Alter Metabotropic Glutamate Receptor 1 Intracellular Localization and Signaling
    Esseltine, Jessica L.
    Willard, Melinda D.
    Wulur, Isabella H.
    Lajiness, Mary E.
    Barber, Thomas D.
    Ferguson, Stephen S. G.
    MOLECULAR PHARMACOLOGY, 2013, 83 (04) : 770 - 780
  • [8] The metabotropic glutamate receptor 1, GRM1: evaluation as a candidate gene for inherited forms of cerebellar ataxia
    Rossi, Pia Irene Anna
    Vaccari, Carlotta Maria
    Terracciano, Alessandra
    Doria-Lamba, Laura
    Facchinetti, Sabrina
    Priolo, Manuela
    Ayuso, Carmen
    De Jorge, Laura
    Gimelli, Stefania
    Santorelli, Filippo Maria
    Ravazzolo, Roberto
    Puliti, Aldamaria
    JOURNAL OF NEUROLOGY, 2010, 257 (04) : 598 - 602
  • [9] Pre-clinical study targeting metabotropic glutamate receptor (GRM1) angiogenesis pathway
    Grabell, Daniel A.
    Wen, Yu
    Semlani, Neha
    Li, Jiadong
    Goydos, James
    CANCER RESEARCH, 2013, 73 (08)
  • [10] A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in metastatic melanoma
    Mehnert, J. M.
    Lee, J. H.
    Shirk, J.
    Bhavsar, D.
    Anosike, O.
    Chan, J. L.
    Shih, W.
    Chen, S.
    Goydos, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345